Zenara Pharma Pvt Ltd

If you are actively looking for niche formulations for your markets, you are in the right place. Let’s meet in Milan at CPHI WW and discuss how we can take these products to the market together Do send us an email to set up a discussion #cphiww #orphandrugs

An inspiring interaction with Mr Bill Gates, founder of Microsoft and equally popular now as the co-chair of Bill & Melinda Gates Foundation. Mr Gates was all ears to Zenara Pharma Pvt Ltd and Biophore India Pharmaceuticals Pvt. Ltd.’s efforts in making treatment options for rare diseases accessible and more affordable, not just in India but globally. We are thankful to Dr Vinod Kumar Paul, Member NITI Aayog, for the opportunity to be on this platform Vishnu Vempati #raredisease #nitiaayog #orphandrugs

A humungous effort by Organization for Rare Diseases India in getting together the healthcare community to raise awareness on rare diseases. It is a continuous effort and Zenara is proud to be playing a part in this and providing solutions for the treatment of these life threatening ailments #raredisease #orphandrugs

Our colleagues from Zenara Pharma Pvt Ltd Biophore India Pharmaceuticals Pvt. Ltd. Vivere Imaging got together to play their part at the Race For 7 organised by Organization for Rare Diseases India to raise awareness on rare diseases and connect the various stakeholders. #raredisease

Zenara proudly supports the cause for rare disease treatment in India. Join us at the Race for 7 across the country on 25 Feb and be a part of this noble cause Organization for Rare Diseases India #racefor7 #raredisease #orphandrugs

We have always claimed that R&D is a significant pillar in our endeavor to roll out complex generics in the market. This claim has been reinforced by the recognition received at CPHI India - India Pharma Awards 2023 in the category 'Excellence in R&D' Congratulations to the team!

3 out of these 4 drugs identified to treat Rare Diseases in India have been launched by Zenara Pharma - a testimony to our commitment to enable quality healthcare in the country, irrespective of the commercial value. Medicines for Rare Diseases are often overlooked due to various reasons but, at Zenara, this is a priority segment with time and resources invested into orphan drug development and manufacturing To know more about our rare disease portfolio, including the pipeline, and to partner with us to take these products to the patients, please message us #raredisease #orphandrugs

We have always claimed that R&D is a significant pillar in our endeavor to roll out complex generics in the market. This claim has been reinforced by the recognition received at CPHI India - India Pharma Awards 2023 in the category 'Excellence in R&D' Congratulations to the team!

3 out of these 4 drugs identified to treat Rare Diseases in India have been launched by Zenara Pharma - a testimony to our commitment to enable quality healthcare in the country, irrespective of the commercial value. Medicines for Rare Diseases are often overlooked due to various reasons but, at Zenara, this is a priority segment with time and resources invested into orphan drug development and manufacturing To know more about our rare disease portfolio, including the pipeline, and to partner with us to take these products to the patients, please message us #raredisease #orphandrugs